Prediabetes is a salient state of hyperglycemia and/or hyperinsulinemia that often precedes a diagnosis of Type 2 diabetes (T2D). It is projected that by 2040, almost 8% of the global population will have prediabetes, with approximately 70% progressing to T2D within their lifetime. Abnormal glucose tolerance increases the risk of associated complications, including cardiovascular disease, stroke, and microvascular diseases, all of which are major contributors to the global healthcare burden. T2D alone is predicted to cost the healthcare system upwards of 490 billion USD by 2030, thus addressing this growing burden is vital. With the dietary and lifestyle changes recommended by Ayurveda, prediabetes can turn into normoglycemia. However, public health message does not effectively explain this. Prediabetes is not recognized a disease state, which may also affect public opinion regarding perceived urgency of treatment and necessity for intervention in Ayurveda, in addition to public view about the risk of illness development to T2D. When it comes to managing prediabetes, Ayurvedic diet and lifestyle therapies are hailed as best practices, while yoga and herbal medications are ideal for individuals who are most at risk of developing type 2 diabetes in the future. Low carbohydrate diets, higher protein diets, time-restricted meals, and high intensity interval exercise are some of the available novel and promising therapies that, when combined, may help people with limited time improve risk factors like weight loss and glycemic control (HbA1c and fasting plasma glucose). In order to target particular groups and individuals, personalized approaches, in conjunction with counselling based on social cognitive theory, may be increasingly used as programmes can be tailored to meet the unique needs and preferences of Ayurveda. This is because large-scale feasibility and adherence are major obstacles to contend with in the rollout of diet and lifestyle interventions.